New Money for Jena High-Tech Company

bm|t beteili­gungs­man­age­ment thürin­gen gmbh is secur­ing the finances of SIRS-Lab GmbH in Jena with a fur­ther injec­tion of cap­i­tal and in so doing, increas­ing its share in the high-tech com­pany to 49 per­cent. In this way, SIRS-Lab is being pro­vided with the finan­cial scope to pro­ceed with its planned devel­op­ments and intro­duce new prod­ucts on the market.

Products for Sepsis Diagnosis

SIRS-Lab devel­ops and pro­duces diag­nos­tic aids for the early diag­no­sis and ther­a­peu­tic con­trol of sep­sis-related ail­ments. Approx­i­mately 150,000 peo­ple fall vic­tim to sep­sis – also pop­u­larly known as blood poi­son­ing – every year in Ger­many, about half of whom die. The founders of SIRS-Lab GmbH are inter­na­tion­ally recog­nised research sci­en­tists and clin­i­cians with spe­cial exper­tise in inten­sive medicine.

At present, the com­pany is already mar­ket­ing biochips for aca­d­e­mic research and for use in the phar­ma­ceu­ti­cal indus­try. Its new prod­ucts are aimed par­tic­u­larly at clin­ics. SIRS-Lab was founded in the year 2000 and employs 26 staff. The com­pany will be exhibit­ing at the “Bio” biotech­nol­ogy fair in Philadel­phia, USA, from the 19^th to the 21^st June, which is the world’s largest fair of its kind.